Unigen pens 100-year plan

Unigen pens 100-year plan:

"Based in Lacey, Washington and in Korea, Unigen studies plant extracts at the gene level in order to gain an understanding as to how they affect gene expression. The company is dedicated to the discovery of botanically derived therapeutic compounds for use in nutraceutical, functional food, cosmeceutical and pharmaceutical products.

As part of the lengthy process of unleashing botanical ingredients through its research and development pipeline, Unigen is investing heavily in human capital in anticipation of a century down the road – when it foresees accelerated convergence of the nutraceutical and cosmetics industries.

“We do have a 100-year business plan and there are key stepping stones that we are diligently attaining,” newly-hired vice president of sales and marketing Douglas Lynch told NutraIngredients-USA.com at SupplySide West. “Part of this comes from our corporate culture being first Korean-based.”"